FDA probe of Abbott facility finds quality control issues

An inspection at the Abbott Laboratories facility in Sturgis, Michigan found a harmful bacteria called Cronobacter sakazakii on the surface of some areas producing its powdered baby formula, the U.S. health regulator said on Tuesday.

Complaints that the facility’s products had caused bacterial infections forced Abbott to recall certain Alimentum, Similac and EleCare baby formulas last month, prompting a probe from the U.S. Food and Drug Administration (FDA).

The inspection from Jan. 31 to March 18 showed https://www.fda.gov/media/157073/download?utm_medium=email&utm_source=govdelivery that Abbott did not have a control system covering all stages of processing to prevent microbe contamination of infant formula.

Personnel working with infant formula also did not wear necessary protective apparel, the FDA said.

“We’re taking this very seriously and are working closely with the FDA to implement corrective actions,” Abbott said in a statement.

No Cronobacter sakazakii was found during the company’s testing of products that were distributed to consumers, Abbott added.

The company also said that the genetic makeup of the Cronobacter sakazakii found at the Michigan plant did not match that of the reported cases.

Cronobacter sakazakii bacteria can cause serious invasive infections and premature infant death.

  • Related Posts

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    Prices of nearly 900 essential medicines, including painkillers and antibiotics, are set to rise by around 0.65 per cent starting 1 April following a directive from India’s drug pricing regulator.…

    Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

    The court also asked Dr Reddy’s to inform it by Friday whether it is willing to drop the “Olymviq” brand name, as the matter centres around alleged trademark similarity with…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

    Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

    NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

    NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

    Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha

    Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha

    Regulation Of Hair Transplant And Cosmetic Clinics Under The Purview Of States, No Plans To Create A Central Database Or Registry: Govt In RS

    Regulation Of Hair Transplant And Cosmetic Clinics Under The Purview Of States, No Plans To Create A Central Database Or Registry: Govt In RS

    24-year-old woman dies during surgery; Five UP doctors booked for negligence

    24-year-old woman dies during surgery; Five UP doctors booked for negligence